Health Policy 2023 Wrapped

This episode is brought to you by Semafor Healthcare.

Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.

Health Affairs's Leslie Erdelack and Rob Lott take cues from Spotify Wrapped to look back to the most important headlines from the first eleven months of 2023. They discuss Medicaid unwinding, drug price negotiations, life after Dobbs, Ozempic, artificial intelligence, COVID-19, affirmative action, and more.

Related Links:

• Maintaining Coverage Gains During Medicaid Unwinding (Health Affairs Forefront)
• The Future Of COVID-19 Vaccine Development (Health Affairs Forefront)
• Arriving At A Fair Price In The Medicare Drug Price Negotiation Program: Considerations From Other Countries (Health Affairs Forefront)
• How Will The Executive Order On Artificial Intelligence Impact Health Care? (Health Affairs Forefront)
• A Year After Dobbs: Diminishing Access To Obstetric-Gynecologic And Maternal-Fetal Care (Health Affairs Forefront)
• T-Swift of stocks: Ozempic is unending markets, despite unknowns (Axios)
• With affirmative action off the table, medical schools plan new diversity tactics (Stat News)
• A roadblock to life-saving addiction treatment is gone. Now what? (NPR)

Subscribe to Semafor Healthcare for free.